Table 1.
NOSPECS |
Class 0: No signs or symptoms |
Class 1: Only signs (limited to upper lid retraction and stare, with or without lid lag) |
Class 2: Soft tissue involvement (edema of conjunctivae and lids, conjunctival injection, etc) |
Class 3: Proptosis |
Class 4: Extraocular muscle involvement (usually with diplopia) |
Class 5: Corneal involvement (primarily due to lagophthalmos) |
Class 6: Sight loss (due to optic nerve involvement) |
VISA |
Vision loss (optic neuropathy) |
Inflammation/congestion and activity in TED |
Strabismus/motility |
Appearance/exposure |
CAS |
Pain |
1: Painful, oppressive feeling on or behind the globe during the last 4 weeks |
2: Pain on attempted up, side, or down gaze during the last 4 weeks |
Redness |
3: Redness of the eyelid(s) |
4: Diffuse redness of the conjunctiva, covering at least one quadrant |
Swelling |
5: Swelling of the eyelid(s) |
6: Chemosis |
7: Swollen caruncle |
8: Increase of proptosis of >2 mm or more during a period between 1 month and 3 months |
Impaired function |
9: Decrease in eye movements in any direction greater than or equal to 5° during a period of 1–3 months |
10: Decrease in visual acuity of greater than or equal to one line on the Snellen chart (using a pinhole) during a period of 1–3 months |
Notes: For each of the signs present, one point is given. The sum of these points defines the activity score.
Abbreviations: TED, thyroid eye disease; CAS, Clinical Activity Score.